Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Legend Biotech ADR is a leading biopharmaceutical company dedicated to developing innovative cell therapies. Specializing in groundbreaking CAR-T cell therapies, it targets cancer treatment. Through cutting-edge biotechnology, Legend Biotech ADR strives to create patient-centric solutions and revolutionize cancer therapy.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Legend Biotech ADR is scheduled to report its next quarterly earnings on 11/17/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Legend Biotech ADR last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at 0.09 USD.
Across its last 3 earnings reports, Legend Biotech ADR stock moved by ±5.1% on average the following day. The largest reaction was +10.5% on 05/12/2026; 2 of 3 reactions were positive.
Legend Biotech ADR has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.